What is hypoplastic MDS?
Hypoplastic MDS refers to a morphologic feature in which the marrow cellularity is low for age (<30% cellularity if <60 years or <20% cellularity if age >60 years), representing approximately 10 to 15% of all MDS cases, but which does not necessarily take into account disease mechanism (3).
Can MDS be surgeons?
Many are primary care doctors, but both DOs and MDs can specialize in dermatology, cardiology, psychiatry or any other medical or surgical field. All doctors — MDs and DOs — can prescribe medication and train to do surgery. They have similar training, too.
How is hypoplastic MDS treated?
Hypoplastic myelodysplastic syndrome (MDS) is characterized by dysplasia and hypocellularity. The treatment of choice for young patients is bone marrow transplantation.
Is MDS a terminal?
MDS is a form of bone marrow cancer, although its progression into leukaemia does not always occur. The failure of the bone marrow to produce mature healthy cells is a gradual process, and therefore MDS is not necessarily a terminal disease. In some patients, however, MDS can progress to AML, Acute Myeloid Leukaemia.
What is hypoplasia?
Hypoplasia refers to a lack of cells in an organ or tissue. It can cause a range of different symptoms depending on where in the body it occurs. Many conditions involve hypoplasia. A person with one of these conditions may experience difficulty with using a certain part of their body.
Is MDS curable?
Management of myelodysplastic syndromes is most often intended to slow the disease, ease symptoms and prevent complications. There’s no cure for myelodysplastic syndromes, but some medications can help slow the progression of the disease. If you have no symptoms, treatment might not be needed right away.
How long can you live with myelodysplasia?
Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454-2465….Survival statistics for MDS.
| IPSS-R risk group | Median survival |
|---|---|
| Low | 5.3 years |
| Intermediate | 3 years |
| High | 1.6 years |
| Very high | 0.8 years |
Can you live 20 years with MDS?
With current treatments, patients with lower-risk types of some MDS can live for 5 years or even longer. Patients with higher-risk MDS that becomes acute myeloid leukemia (AML) are likely to have a shorter life span. About 30 out of 100 MDS patients will develop AML.